CCL27 and acute myeloid leukemia: However, the uncertainty of ILC effects comprising ILC3 in the progression of tumors may present significant uncertainties regarding their possible therapeutic employment in AML, although their ability to stimulate tissue repair and protect against pathogens may be advantageous in AML subjects undergoing chemotherapy or radiotherapy before HSCT.